Zhonghua Yi Xue Za Zhi

[Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy].

Related Articles [Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2372-2377 Authors: Pei GQ, Qin AY, Wang SQ, Tan L, Tang Y, Qin W Abstract Objective: To investigate the effects of serum immunoglobulin A/complement factor 3 (IgA/C3) ratio and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy. Methods: From January...

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Epidemiological analysis and screening mode of breast cancer screening in Fujian province from 2015 to 2018].

Related Articles [Epidemiological analysis and screening mode of breast cancer screening in Fujian province from 2015 to 2018]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2367-2371 Authors: Huang XX, Huang XX, Chen ZW, Wu JB, Wang HM Abstract Objective: To analyze the screening results of breast cancer in rural women in Fujian Province from 2015 to 2018, and to explore the screening mode of breast cancer. Methods: Breast cancer screening was...

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Clinical study of exploring new axillary zone in sentinel lymph node biopsy of breast cancer].

Related Articles [Clinical study of exploring new axillary zone in sentinel lymph node biopsy of breast cancer]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2363-2366 Authors: Fu ZL, Tian L, Zhang CY, Feng R Abstract Objective: To explore the application of axillary reverse mapping (ARM) in breast cancer sentinel lymph node biopsy (SLNB), and to collect and record patient's data during operation. Through the specific experimental data, the anatomical...

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Effect of overexpression of integrin β2 on clinical prognosis in triple negative breast cancer].

Related Articles [Effect of overexpression of integrin β2 on clinical prognosis in triple negative breast cancer]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2358-2362 Authors: Puerkaiti P, Fan JJ, Ma BL Abstract Objective: To investigate the clinical significance of the expression of integrin β2 (ITGB2) and tumor infiltrating dendritic cells CD80 and CD86 in triple negative breast cancer (TNBC). Methods: The expression levels of ITGB2 and...

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study].

Related Articles [Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2351-2357 Authors: Bian L, Xu BH, Di LJ, Wang T, Wang XJ, Jiao SC, Yang JL, Tong ZS, Liu J, Feng JF, Liu DG, Yu QT, Liu YP, Ma Y, Yu H, Jiang ZF Abstract ...

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Benefit/risk assessment and issues related to antibiotic use of Helicobacter pylori eradication in elderly individuals].

Related Articles [Benefit/risk assessment and issues related to antibiotic use of Helicobacter pylori eradication in elderly individuals]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2343-2345 Authors: Wang JB PMID: 32791809 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Several issues on amoxicillin in Helicobacter pylori eradication therapy].

Related Articles [Several issues on amoxicillin in Helicobacter pylori eradication therapy]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2340-2342 Authors: Yang GB PMID: 32791808 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Successful eradication of Helicobacter pylori in initial treatment: deep integration of personalized and standardized therapy].

Related Articles [Successful eradication of Helicobacter pylori in initial treatment: deep integration of personalized and standardized therapy]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2336-2339 Authors: Gao HJ, Zhan BJ PMID: 32791807 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[The pathological evaluation of IgA nephropathy].

Related Articles [The pathological evaluation of IgA nephropathy]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2332-2335 Authors: Zeng CH PMID: 32791806 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Treatment of IgA nephropathy in the era of evidence-based medicine and personalized medicine].

Related Articles [Treatment of IgA nephropathy in the era of evidence-based medicine and personalized medicine]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2328-2331 Authors: Li C, Li H PMID: 32791805 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[Key points of diagnosis and treatment for HER2 positive breast cancer].

Related Articles [Key points of diagnosis and treatment for HER2 positive breast cancer]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2324-2327 Authors: Xu FR, Jiang ZF PMID: 32791804 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

[More importance should be attached to appropriate application of antibiotics in the treatment of Helicobacter pylori].

Related Articles [More importance should be attached to appropriate application of antibiotics in the treatment of Helicobacter pylori]. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2321-2323 Authors: Hu FL PMID: 32791803 [PubMed - in process]

Zhonghua Yi Xue Za Zhi

Sat Aug 15, 2020 14:50

Mark above section as read